Hangzhou Biotest Biotech Co (SHSE:688767) Dividend Payout Ratio: 0.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688767 Hangzhou Biotest Biotech Co Ltd SHSE:688767
71 GF Score
Price ¥34.50
GF Value ¥26.87
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Hangzhou Biotest Biotech Co Dividend Payout Ratio?

Hangzhou Biotest Biotech Co SHSE:688767 -5.48% 71 Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus rates SHSE:688767 with a GF Score™ of 71/100 and a GF Value™ of ¥26.87 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 133 Biotechnology companies, Hangzhou Biotest Biotech Co ranks worse than 91.73% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Hangzhou Biotest Biotech Co's Dividend Payout Ratio for the months ended in Mar. 2026 was 0.00.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Hangzhou Biotest Biotech Co Ltd is 2.55, which seems too high.

The historical rank and industry rank for Hangzhou Biotest Biotech Co's Dividend Payout Ratio or its related term are showing as below:

SHSE:688767' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.42   Med: 1.84   Max: 5.95
Current: 2.55

During the past 9 years, the highest Dividend Payout Ratio of Hangzhou Biotest Biotech Co was 5.95. The lowest was 0.42. And the median was 1.84.

SHSE:688767's Dividend Payout Ratio is ranked worse than
91.73% of 133 companies
in the Biotechnology industry
Industry Median: 0.44 vs SHSE:688767: 2.55

As of today (2026-07-17), the Dividend Yield % of Hangzhou Biotest Biotech Co is 1.92%.

During the past 9 years, the highest Trailing Annual Dividend Yield of Hangzhou Biotest Biotech Co was 10.81%. The lowest was 1.72%. And the median was 3.39%.

Hangzhou Biotest Biotech Co's Dividends per Share for the months ended in Mar. 2026 was ¥0.00.

During the past 12 months, Hangzhou Biotest Biotech Co's average Dividends Per Share Growth Rate was -23.10% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -20.60% per year.

During the past 9 years, the highest 3-Year average Dividends Per Share Growth Rate of Hangzhou Biotest Biotech Co was -20.60% per year. The lowest was -20.60% per year. And the median was -20.60% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Hangzhou Biotest Biotech Co (SHSE:688767) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Hangzhou Biotest Biotech Co Dividend Payout Ratio Related Terms

Hangzhou Biotest Biotech Co Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Hangzhou Biotest Biotech Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou Biotest Biotech Co Dividend Payout Ratio Chart

Hangzhou Biotest Biotech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only 0.00 0.42 2.97 0.71 5.95

Hangzhou Biotest Biotech Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.49 28.56 0.00 0.00 0.00

SHSE:688767 vs VRTX, REGN, ALNY: Dividend Payout Ratio Comparison

For the Biotechnology subindustry, Hangzhou Biotest Biotech Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hangzhou Biotest Biotech Co Dividend Payout Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hangzhou Biotest Biotech Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Hangzhou Biotest Biotech Co's Dividend Payout Ratio falls into.


SHSE:688767
71GF Score
Hangzhou Biotest Biotech Co Ltd SHSE:688767
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hangzhou Biotest Biotech Co Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Hangzhou Biotest Biotech Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2025 )/ EPS without NRI (A: Dec. 2025 )
=1.071/ 0.18
=5.95

Hangzhou Biotest Biotech Co's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2026 )/ EPS without NRI (Q: Mar. 2026 )
=0/ -0.067
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 0.00 mean?
Hangzhou Biotest Biotech Co (SHSE:688767) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Hangzhou Biotest Biotech Co and its competitors. Over the past decade, Hangzhou Biotest Biotech Co's Dividend Payout Ratio has ranged from 0.42 to 5.95. According to the industry distribution chart, Hangzhou Biotest Biotech Co ranks #122 out of 133 companies in the Biotechnology industry, placing it in the top 91.7%.
Is Hangzhou Biotest Biotech Co's Dividend Payout Ratio too high?
Hangzhou Biotest Biotech Co's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.42 to a high of 5.95. Based on the distribution chart, Hangzhou Biotest Biotech Co ranks #122 out of 133 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Hangzhou Biotest Biotech Co has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hangzhou Biotest Biotech Co's Dividend Payout Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Hangzhou Biotest Biotech Co ranks #122 out of 133 companies for Dividend Payout Ratio. This places Hangzhou Biotest Biotech Co in the lower half of its industry. The industry median Dividend Payout Ratio is 0.44. Historically, Hangzhou Biotest Biotech Co's own Dividend Payout Ratio has ranged from 0.42 to 5.95 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Biotechnology company?
The median Dividend Payout Ratio among Biotechnology companies is 0.44, based on 133 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Hangzhou Biotest Biotech Co and its competitors. For the Biotechnology industry, the median Dividend Payout Ratio is 0.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hangzhou Biotest Biotech Co's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou Biotest Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Hangzhou Biotest Biotech Co (SHSE:688767) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥26.87, compared to a current price of ¥34.50 — trading 28.4% above its estimated fair value. The current Dividend Payout Ratio is 0.00. Hangzhou Biotest Biotech Co's overall GF Score™ is 71/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Hangzhou Biotest Biotech Co (SHSE:688767), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hangzhou Biotest Biotech Co (SHSE:688767) Overvalued in 2026?

Based on GuruFocus' analysis, Hangzhou Biotest Biotech Co stock appears to be overvalued. The current stock price of ¥34.50 is trading 28.4% above its estimated GF Value™ of ¥26.87. GuruFocus considers Hangzhou Biotest Biotech Co to be Modestly Overvalued.

Key valuation signals for SHSE:688767:

  • Dividend Payout Ratio: 0.00
  • GF Value™: ¥26.87 vs. price of ¥34.50 (28.4% above fair value)
  • GF Score™: 71/100 with 7 warning signs

No single metric tells the full story. See the SHSE:688767 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hangzhou Biotest Biotech Co Business Description

Address No. 17, Futai Road, Zhongtai Street, Yuhang District, Zhejiang Province, Hangzhou, CHN, 311121
Hangzhou Biotest Biotech Co Ltd is engaged in the research and development, manufacturing, sales and service of in vitro diagnostic reagents, raw materials and instruments.
71GF Score

Get the complete analysis for SHSE:688767

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥34.50
Price
¥26.87
GF Value